Statins × adverse events & safety

TrialClinical therapeutics2003

A retrospective analysis of the effect of noncompliance on time to first major adverse cardiac event in LIPS.

Emmanuel Lesaffre et al.PubMed ↗Publisher ↗

What the trial testedas reported · 1,677 people · 2003

No range given

Reported higher adverse events & safety, no range given

2.3×

Bigger than 8 in 10 for adverse events & safety

As reported

RR 2.27, no interval

One number in the abstract

the abstract, start to end

patients who stayed on fluvastatin (RR = 2.27; P < 0.001; 95% CI, 1.60-3.23)

← favours treatmentfavours comparator →
could be chance
No interval given · direction only, strength unknown
Adverse events & safety
RR 2.27
StatinsAdverse events & safety

Statins × adverse events & safetyharms?mixed

unlikelylikely
0.160.00 without it
← favours treatmentfavours comparator →
this papermore certainless certain
1 / 5

5 papers cite it

2003
2004
2005
2006
2007
2008
2009
2010
2011
2012
2013
2014
2015
2016
2017
2018
this paperpooled itcites it
Full record →Abstract, authors, funding and every citing paper · PMID 14604742